Correction to Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth.
Jiayan LangXiao ZhaoXiuchao WangYing ZhaoYiye LiRuifang ZhaoKeman ChengYao LiXuexiang HanXiaowei ZhengHao QinMarzieh GeranpayehvagheiJian ShiGregory J AndersonJihui HaoHe RenGuangjun NiePublished in: ACS nano (2020)